More about

Interferon

News
March 29, 2022
4 min read
Save

Only highest-dose iberdomide outperforms placebo in SLE; adverse events high

Only highest-dose iberdomide outperforms placebo in SLE; adverse events high

Iberdomide, a novel oral cereblon modulator, was superior to a placebo only in patients with systemic lupus erythematosus who received the highest dose in a phase 2 trial, albeit with a high incidence of adverse events, according to data.

News
October 19, 2021
2 min read
Save

Interferon adds no clinical benefit for hospitalized patients with COVID-19

Interferon adds no clinical benefit for hospitalized patients with COVID-19

Combining the immunomodulator interferon beta-1a with remdesivir did not improve treatment among hospitalized adults with COVID-19 compared with remdesivir alone, data from a clinical trial showed.

News
August 30, 2021
2 min read
Save

Dysfunctional red blood cells in children may be 'root cause' of lupus

Dysfunctional red blood cells in children may be 'root cause' of lupus

The presence of mature red blood cells that still contain mitochondria is associated with higher systemic lupus erythematosus disease activity, according to data published in Cell.

News
August 09, 2021
2 min read
Save

'The wild, wild west': COVID-19 care improves amid hunt for more effective therapies

'The wild, wild west': COVID-19 care improves amid hunt for more effective therapies

Clinicians have an increasing number of options to treat patients with all stages of COVID-19 infection, from pauci-symptomatic early infection to those with long hauler syndromes, noted a speaker at the 2021 Rheumatology Nurses Society annual conference.

News
May 18, 2021
3 min read
Save

Serum biomarkers 'clearly separate' COVID-19 from classic cytokine storm syndromes

Serum biomarkers 'clearly separate' COVID-19 from classic cytokine storm syndromes

Increased interleukin‐1Ra and IL‐8 serum levels, and other biomarker profiles, “clearly separate” COVID-19 from macrophage activation syndrome and secondary hemophagocytic lymphohistiocytosis, according to data published in Arthritis & Rheumatology.

News
April 21, 2021
3 min read
Save

TULIP: Anifrolumab exhibits 'many more pluses than minuses' in lupus

TULIP: Anifrolumab exhibits 'many more pluses than minuses' in lupus

After decades of research advances and reverses, blocking the interferon receptor in lupus may finally be showing consistent clinical benefit, according to a presentation at the United Rheumatology Spring Virtual conference.

News
January 21, 2021
13 min read
Save

Interferon in lupus: A complex pathway for ‘1,000 different diseases’

Interferon in lupus: A complex pathway for ‘1,000 different diseases’

The possible FDA approval of a drug targeting the interferon pathway in lupus is the culmination of decades of work by clinicians and researchers alike. Yet, given the bewildering complexity of both interferon and lupus, this moment is likely only the midpoint of a much longer narrative.

News
November 24, 2020
1 min read
Save

Inhaled interferon beta improves odds of recovery from COVID-19

Inhaled interferon beta improves odds of recovery from COVID-19

Hospitalized patients with COVID-19 who received inhaled nebulized interferon beta-1a were twice as likely to improve and recover than those who received placebo, according to data published in The Lancet Respiratory Medicine.

News
September 25, 2020
4 min read
Save

What is STING’s real name?

What is STING’s real name?

Imagine my surprise when I opened Science last month and was reminded that “Sting” is no longer the sole province of Gordon Matthew Thomas Sumner, CBE — songwriter, singer and bass player extraordinaire, who helped take The Police to fame and fortune with such standards as “Roxanne” and “Walking on the Moon” back in the 20th century.

News
July 21, 2020
2 min read
Save

Inhaled interferon beta shows promise for severe COVID-19

Inhaled interferon beta shows promise for severe COVID-19

Inhaled interferon beta lowered the risk for developing severe infection and improved the likelihood of recovery from COVID-19 compared with placebo, according to early data released by Synairgen.

View more